Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

bromocriptine

bromocriptine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Cycloset TABLET, ORAL 0.8 mg    
Parlodel TABLET, ORAL 2.5 mg      
Comments:

ORDERED FORMULATION

THRAPEUTIC INTERCHANGE

bromocriptine (Cycloset)

  • 0.8 mg tablet once Daily
  • TWO 0.8 mg tablets (Total: 1.6 mg) once Daily
  • THREE 0.8 mg tablets (Total: 2.4 mg) once Daily
  • FOUR 0.8 mg tablets (Total: 3.2 mg) once Daily
  • FIVE 0.8 mg tablets (Total: 4 mg) once Daily
  • SIX 0.8 mg tablets (Total: 4.8 mg) once Daily

bromocriptine (Parlodel)

  • discontinue drug with no replacement dose
  • 2.5 mg tablet once Daily
  • 2.5 mg tablet once Daily
  • 2.5 mg tablet once Daily
  • TWO 2.5 mg tablets (Total: 5 mg) once Daily
  • TWO 2.5 mg tablets (Total: 5 mg) once Daily

Cycloset (bromocriptine 0.8 mg tab) is indicated to treat type 2 diabetes. Initial dose is 0.8 mg once daily, with maintenance doses ranging up to 4.8 mg daily. Cycloset should be interchanged to the generic bromocriptine tablet in approximately equal dosage regimens ( either 2.5 mg or 5 mg once daily). The 0.8 mg dose is for initiation only and should be deferred to the outpatient setting. Alternatively, patients may use their own supply.

Reviewed: May 27, 2014 (Cycloset)

Last updated: Dec. 19, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved